Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Structural insights into loss of function of a pore forming toxin and its role in pneumococcal adaptation to an intracellular lifestyle.

Tytuł:
Structural insights into loss of function of a pore forming toxin and its role in pneumococcal adaptation to an intracellular lifestyle.
Autorzy:
Badgujar DC; Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, Maharashtra, India.
Anil A; Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, Maharashtra, India.
Green AE; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
Surve MV; Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, Maharashtra, India.
Madhavan S; Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, Maharashtra, India.
Beckett A; Division of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
Prior IA; Division of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
Godsora BK; Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, Maharashtra, India.
Patil SB; Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, Maharashtra, India.
More PK; Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, Maharashtra, India.
Sarkar SG; Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, Maharashtra, India.
Mitchell A; Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Banerjee R; Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, Maharashtra, India.
Phale PS; Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, Maharashtra, India.
Mitchell TJ; Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Neill DR; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
Bhaumik P; Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, Maharashtra, India.
Banerjee A; Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, Maharashtra, India.
Źródło:
PLoS pathogens [PLoS Pathog] 2020 Nov 20; Vol. 16 (11), pp. e1009016. Date of Electronic Publication: 2020 Nov 20 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science, c2005-
MeSH Terms:
Adaptation, Physiological*
Loss of Function Mutation*
Inflammation/*microbiology
Pneumococcal Infections/*microbiology
Streptococcus pneumoniae/*physiology
Streptolysins/*metabolism
Amino Acid Sequence ; Animals ; Bacterial Proteins/genetics ; Bacterial Proteins/metabolism ; Cell Membrane/microbiology ; Cholesterol/metabolism ; Cytoplasm/microbiology ; Female ; Humans ; Mice ; Models, Structural ; Perforin/genetics ; Perforin/metabolism ; Sequence Alignment ; Streptococcus pneumoniae/genetics ; Streptolysins/genetics
References:
Elife. 2017 Mar 21;6:. (PMID: 28323617)
Nat Microbiol. 2019 Jan;4(1):62-70. (PMID: 30420782)
PLoS One. 2013;8(4):e61300. (PMID: 23577214)
Q Rev Biol. 1996 Mar;71(1):37-78. (PMID: 8919665)
J Med Microbiol. 2010 Jul;59(Pt 7):808-814. (PMID: 20339017)
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Aug;1863(8):795-805. (PMID: 29679741)
PLoS One. 2014 Aug 08;9(8):e103625. (PMID: 25105894)
Future Microbiol. 2012 Jan;7(1):33-46. (PMID: 22191445)
Clin Microbiol Rev. 2015 Jul;28(3):871-99. (PMID: 26085553)
J Biol Chem. 2014 Jun 6;289(23):15942-50. (PMID: 24790078)
Cell Host Microbe. 2017 Jan 11;21(1):73-83. (PMID: 28081446)
mBio. 2011 May 24;2(3):e00092-11. (PMID: 21610120)
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67. (PMID: 21460454)
Nature. 1985 Sep 12-18;317(6033):106. (PMID: 4033793)
J Infect Dis. 2004 Mar 1;189(5):785-96. (PMID: 14976594)
Infect Immun. 2005 Aug;73(8):4653-67. (PMID: 16040978)
mBio. 2020 May 19;11(3):. (PMID: 32430472)
Cell. 1997 May 30;89(5):685-92. (PMID: 9182756)
J Infect Dis. 2007 Sep 15;196(6):936-44. (PMID: 17703426)
PLoS One. 2015 Aug 07;10(8):e0134055. (PMID: 26252211)
PLoS Pathog. 2010 Nov 11;6(11):e1001191. (PMID: 21085613)
J Biol Chem. 2009 May 22;284(21):14645-56. (PMID: 19307185)
Sci Rep. 2015 Sep 03;5:13293. (PMID: 26333773)
Clin Infect Dis. 2006 Feb 15;42(4):451-9. (PMID: 16421787)
Comput Struct Biotechnol J. 2015 Apr 08;13:241-7. (PMID: 25904996)
Nat Rev Microbiol. 2008 Nov;6(11):827-37. (PMID: 18923410)
PLoS One. 2015 Aug 28;10(8):e0137108. (PMID: 26317436)
mBio. 2012 Sep 25;3(5):. (PMID: 23015736)
PLoS Pathog. 2013;9(6):e1003394. (PMID: 23762025)
Nat Microbiol. 2018 May;3(5):600-610. (PMID: 29662129)
Curr Opin Immunol. 2018 Feb;50:88-93. (PMID: 29253642)
Nat Commun. 2019 Jul 16;10(1):3060. (PMID: 31311921)
Nature. 2012 Jan 15;482(7385):414-8. (PMID: 22246324)
Nat Rev Microbiol. 2018 Jun;16(6):355-367. (PMID: 29599457)
Nucleic Acids Res. 2003 Jul 1;31(13):3381-5. (PMID: 12824332)
J Immunol. 2008 May 1;180(9):6246-54. (PMID: 18424747)
Pharm Res. 2014 Jan;31(1):97-103. (PMID: 23881305)
PLoS One. 2015 Mar 23;10(3):e0119823. (PMID: 25798590)
Infect Immun. 2017 Dec 19;86(1):. (PMID: 29061707)
Cell. 2017 Jan 26;168(3):503-516.e12. (PMID: 28129542)
J Biol Chem. 2002 Mar 29;277(13):11597-605. (PMID: 11799121)
J Clin Microbiol. 2006 Jan;44(1):151-9. (PMID: 16390963)
J Struct Biol. 2016 Feb;193(2):132-40. (PMID: 26688057)
PLoS Pathog. 2018 Oct 31;14(10):e1007396. (PMID: 30379943)
Biochim Biophys Acta. 2016 Nov;1860(11 Pt A):2498-2509. (PMID: 27481675)
mBio. 2016 Nov 15;7(6):. (PMID: 27935839)
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32. (PMID: 15572765)
Infect Immun. 2014 Aug;82(8):3289-98. (PMID: 24866797)
J Infect Dis. 2005 Sep 1;192(5):791-800. (PMID: 16088828)
Biochem Biophys Res Commun. 2008 Apr 11;368(3):786-92. (PMID: 18261465)
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21. (PMID: 20124702)
J Clin Microbiol. 2003 Nov;41(11):4966-70. (PMID: 14605125)
Cell Death Differ. 2017 May;24(5):917-928. (PMID: 28387756)
J Bacteriol. 2015 Mar;197(5):807-18. (PMID: 25512311)
Methods Enzymol. 1974;31:172-80. (PMID: 4370662)
PLoS Pathog. 2018 Jul 16;14(7):e1007168. (PMID: 30011336)
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1966-71. (PMID: 12569171)
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674. (PMID: 19461840)
Biochem J. 1998 Feb 1;329 ( Pt 3):571-7. (PMID: 9445384)
J Mol Biol. 1968 Apr 28;33(2):491-7. (PMID: 5700707)
Cell Rep. 2013 May 30;3(5):1369-77. (PMID: 23665225)
Sci Rep. 2015 Sep 25;5:14352. (PMID: 26403197)
Clin Infect Dis. 2018 Jun 18;67(1):42-49. (PMID: 29324986)
J Bacteriol. 1996 Oct;178(20):6087-90. (PMID: 8830714)
Nat Struct Mol Biol. 2004 Aug;11(8):697-705. (PMID: 15235590)
Grant Information:
204457/Z/16/Z United Kingdom WT_ Wellcome Trust
Substance Nomenclature:
0 (Bacterial Proteins)
0 (Streptolysins)
0 (plY protein, Streptococcus pneumoniae)
126465-35-8 (Perforin)
97C5T2UQ7J (Cholesterol)
Entry Date(s):
Date Created: 20201120 Date Completed: 20210208 Latest Revision: 20210208
Update Code:
20240105
PubMed Central ID:
PMC7717573
DOI:
10.1371/journal.ppat.1009016
PMID:
33216805
Czasopismo naukowe
The opportunistic pathogen Streptococcus pneumoniae has dual lifestyles: one of an asymptomatic colonizer in the human nasopharynx and the other of a deadly pathogen invading sterile host compartments. The latter triggers an overwhelming inflammatory response, partly driven via pore forming activity of the cholesterol dependent cytolysin (CDC), pneumolysin. Although pneumolysin-induced inflammation drives person-to-person transmission from nasopharynx, the primary reservoir for pneumococcus, it also contributes to high mortality rates, creating a bottleneck that hampers widespread bacterial dissemination, thus acting as a double-edged sword. Serotype 1 ST306, a widespread pneumococcal clone, harbours a non-hemolytic variant of pneumolysin (Ply-NH). Performing crystal structure analysis of Ply-NH, we identified Y150H and T172I as key substitutions responsible for loss of its pore forming activity. We uncovered a novel inter-molecular cation-π interaction, governing formation of the transmembrane β-hairpins (TMH) in the pore state of Ply, which can be extended to other CDCs. H150 in Ply-NH disrupts this interaction, while I172 provides structural rigidity to domain-3, through hydrophobic interactions, inhibiting TMH formation. Loss of pore forming activity enabled improved cellular invasion and autophagy evasion, promoting an atypical intracellular lifestyle for pneumococcus, a finding that was corroborated in in vivo infection models. Attenuation of inflammatory responses and tissue damage promoted tolerance of Ply-NH-expressing pneumococcus in the lower respiratory tract. Adoption of this altered lifestyle may be necessary for ST306 due to its limited nasopharyngeal carriage, with Ply-NH, aided partly by loss of its pore forming ability, facilitating a benign association of SPN in an alternative, intracellular host niche.
Competing Interests: The authors have declared that no competing interests exist.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies